You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ULN upper limit of the normal range

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monocarboxylate Transporter 8 Deficiency Trial (Tiratricol, Placebo)

Not yet recruiting
  • Monocarboxylate Transporter 8 Deficiency
  • (no location specified)
Oct 11, 2022

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

TTP Patients: Italian Experience (ROSCAPLI)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura, Acquired
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
    Feb 21, 2022

    Heart Failure With Reduced Ejection Fraction Trial (Shengxian Quyu Decoction, Placebo)

    Not yet recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Shengxian Quyu Decoction
    • Placebo
    • (no location specified)
    Dec 8, 2022

    Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

    Completed
    Has Results
    • Carcinoma
    • Renal Cell
    • London, United Kingdom
      Pfizer UK
    Jan 9, 2023

    Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Lone Tree, Colorado
    • +123 more
    Dec 21, 2022

    Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

    Not yet recruiting
    • Primary Biliary Cholangitis (PBC)
    • (no location specified)
    Aug 29, 2023

    Caplacizumab-treated Pediatric Immune-mediated Thrombocytopenic

    Active, not recruiting
    • Immune-mediated Thrombocytopenic Purpura
    • Chilly-Mazarin, France
      Sanofi-Aventis
    Aug 8, 2022

    MDD (MDD) Trial (HS-10353 30mg oral capsules, HS-10353 50mg oral capsules, Placebo for HS-10353 30mg capsules)

    Not yet recruiting
    • Major Depressive Disorder (MDD)
    • HS-10353 30mg oral capsules
    • +3 more
    • (no location specified)
    Jul 10, 2023

    Pharmacogenetics of Liver Toxicity in Multiple Sclerosis Treated

    Recruiting
    • Multiple Sclerosis
    • Genetic polymorphism
    • Measurement of fingolimod and fingolimod-phosphate concentrations
    • Caen, France
      Caen University Hospital
    Aug 23, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Whittier, California
    • +8 more
    Nov 29, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Feb 22, 2023

    Hypoparathyroidism Trial in Worldwide (rhPTH(1-84))

    Terminated
    Has Results
    • Hypoparathyroidism
    • rhPTH(1-84)
    • Lexington, Kentucky
    • +9 more
    Sep 30, 2022

    NSCLC Trial in United States (Imprime PGG, MK-3475)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Chicago, Illinois
    • +4 more
    Oct 6, 2022

    Opioid Withdrawal, Opioid Craving, Opioid Use Disorder Trial in Baltimore (Epidiolex 100 mg/mL Oral Solution, Cherry Syrup Oral

    Completed
    • Opioid Withdrawal
    • +2 more
    • Epidiolex 100 mg/mL Oral Solution
    • Cherry Syrup Oral Solution
    • Baltimore, Maryland
      Johns Hopkins University
    Jul 1, 2022

    Lupus Nephritis Trial in Worldwide (Mycophenolate Mofetil/Mycophenolic Acid, Obinutuzumab, Placebo)

    Active, not recruiting
    Has Results
    • Lupus Nephritis
    • Mycophenolate Mofetil/Mycophenolic Acid
    • +4 more
    • La Jolla, California
    • +45 more
    Nov 14, 2022

    Corona Virus Infection Trial in Worldwide (Sarilumab SAR153191, Placebo)

    Completed
    Has Results
    • Corona Virus Infection
    • Sarilumab SAR153191
    • Placebo
    • Caba, Argentina
    • +46 more
    Mar 15, 2022

    Chronic Hepatitis b Trial in Tainan (Tenofovir Alafenamide)

    Recruiting
    • Chronic Hepatitis b
    • Tenofovir Alafenamide
    • Tainan, Taiwan
      National Cheng-Kung University Hospital
    Dec 18, 2020

    Celiac Disease Trial in Spain

    Recruiting
    • Celiac Disease
      • Terrassa, Barcelona, Spain
      • +5 more
      Aug 10, 2023

      Hyperkalemia Trial in Miami (Patiromer)

      Not yet recruiting
      • Hyperkalemia
      • Miami, Florida
        Investigator Site 84003
      Mar 10, 2023

      Germ Cell Tumors, Testicular Tumors, Non Seminomatous Germ Cell Tumors Trial in Indianapolis, Philadelphia (Pembrolizumab)

      Terminated
      Has Results
      • Germ Cell Neoplasms
      • +6 more
      • Indianapolis, Indiana
      • +1 more
      Jul 7, 2022

      Ulcerative Colitis Trial in Worldwide (CP-690,500 5 mg, CP-690,550 10 mg)

      Terminated
      Has Results
      • Ulcerative Colitis
      • CP-690,500 5 mg
      • CP-690,550 10 mg
      • Mobile, Alabama
      • +79 more
      Aug 3, 2022

      Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

      Active, not recruiting
      • Ovarian Cancer
      • +3 more
      • Duarte, California
      • +6 more
      Jan 21, 2023

      Adhesive Capsulitis Trial in Swabi (STRAIN COUNTER STRAIN GROUP, ACTIVE RELESAE TECHNIQUE GROUP)

      Recruiting
      • Adhesive Capsulitis
      • STRAIN COUNTER STRAIN GROUP
      • ACTIVE RELESAE TECHNIQUE GROUP
      • Swabi, Pakistan
        Bacha Khan Medical Complex Swabi (BKMCS) and District Headquarte
      Sep 15, 2022

      Ravulizumab in Italian Paroxysmal Nocturnal Hemoglobinuria

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Brescia, Italy
      • +5 more
      Jul 13, 2022